STAGE IV BREAST CANCER AJCC V6 AND V7
Clinical trials for STAGE IV BREAST CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV BREAST CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE IV BREAST CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could adding an immunotherapy drug improve treatment for advanced breast cancer?
Disease control CompletedThis study tested whether adding the immunotherapy drug atezolizumab to standard chemotherapy and targeted therapy helps people with HER2-positive breast cancer that has spread. About 190 adults with advanced or recurrent disease took part. The goal was to see if the combination …
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New hope for Hard-to-Treat breast cancer: drug combo shows promise
Disease control CompletedThis study tested whether adding the drug veliparib to standard chemotherapy (cisplatin) helps people with a fast-growing type of breast cancer called triple-negative or BRCA-related breast cancer, including those whose cancer has spread to the brain. About 344 adults took part. …
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New combo shows promise for older breast cancer patients
Disease control CompletedThis study looked at how well older adults (70+) with a common type of advanced breast cancer tolerate a combination of the targeted drug palbociclib and hormone therapy (letrozole or fulvestrant). The goal was to understand side effects and find factors beyond age that might pre…
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 06, 2026 16:01 UTC